World
SOPHiA GENETICS and Element Biosciences Partner to Merge Sequencing and AI Analytics for Precision Medicine
SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the pac...
November 12, 2025 | News
Waters Launches Empower-Integrated Charged Aerosol Detector to Enhance LC-CAD Accuracy and Reliability
Drives efficiency and reliability in Quality Control and Development environments, integrating seamlessly with world-class Empower™ Chromatography ...
November 12, 2025 | News
Primrose Bio Launches Prima RNApols™ ExTend Cap AU to Enhance Self-Amplifying mRNA Vaccine Manufacturing
Primrose Bio, Inc. ("Primrose"), a company with proprietary therapeutic manufacturing technologies, announced the launch of Prima RNApols™ ...
November 11, 2025 | News
Insilico Medicine and Eli Lilly Expand Collaboration to Accelerate AI-Driven Drug Discovery
Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced a research collabor...
November 11, 2025 | News
ERS Genomics Grants CRISPR/Cas9 Patent Access to Dyadic to Advance Animal-Free Protein and Enzyme Production
ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Dyadic Applied BioSolutions ('Dyadic'), a global biotechnology company producing precision-...
November 11, 2025 | News
High-Throughput Vaccine Production: The Future of Scalable, Rapid Immunisation
Vaccines remain the cornerstone of infectious disease control, but traditional development pathways are slow and resource‐intensive. Modern chall...
November 10, 2025 | Analysis
Top Global Proficiency Testing Companies Setting New Standards in Laboratory Accuracy
Proficiency testing (PT) is a form of external quality assurance in which laboratories analyze identical samples and compare results to evaluate performanc...
November 10, 2025 | News
Eli Lilly Partners with SanegeneBio to Advance RNAi Therapies for Metabolic Diseases
-Companies will collaborate on RNAi research for metabolic disease targets SanegeneBio, a clinical-stage biotechnology company developing innov...
November 10, 2025 | News
PolyActiva and RareSight Forge Strategic Partnership to Develop Sustained-Release Therapies for Rare Pediatric Retinal Diseases
Partnership Leverages PolyActiva’s PREZIA™ Drug Delivery Platform Technology and RareSight’s Expertise in Rare Diseases to Advance Nove...
November 07, 2025 | News
Mölnlycke Establishes First Wound Care Manufacturing Site in China to Strengthen Local Production and Supply Chain Resilience
Mölnlycke® Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, is celebrating the commencement of its new wound car...
November 06, 2025 | News
Nona Biosciences Expands Partnership with Umoja Biopharma to Advance Next-Generation In Vivo CAR-T Therapies
Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to I™), announced an evaluation and licen...
November 06, 2025 | News
iLeukon’s mRNA IL-2 Therapy ILKN421H Achieves 80% Response Rate in Lung Cancer Trial
ILKN421H is a novel lipid nanoparticle (LNP)-formulated mRNA encoding a non-alpha HSA–IL-2v fusion protein and dominantly expressed in lymphoid org...
November 05, 2025 | News
AVEO and HiberCell Partner to Develop First-in-Human PERK Inhibitor for Kidney Cancer
First-in-Human PERK inhibitor (HC-5404) to be developed in combination with AVEO's FOTIVDA® (tivozanib) for RCC – – AVEO...
November 05, 2025 | News
Phenomix’s MyPhenome Test Validates GLP-1 Response Prediction Across 88,000 Patients
Studies presented at Obesity Week 2025 validate the test's ability to predict weight-loss response to GLP-1 drugs like semaglutide, including in ...
November 05, 2025 | Report
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
